Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair

Johnston, Simon J.; Ahmad, Dena; Aleskandarany, Mohammed A.; Kurozumi, Sasagu; Nolan, Chris C.; Diez-Rodriguez, Maria; Green, Andrew R.; Rakha, Emad A.

doi:10.1186/s12885-018-4924-2

Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair

Johnston, Simon J.; Ahmad, Dena; Aleskandarany, Mohammed A.; Kurozumi, Sasagu; Nolan, Chris C.; Diez-Rodriguez, Maria; Green, Andrew R.; Rakha, Emad A.

Authors

Simon J. Johnston

Dena Ahmad

Mohammed A. Aleskandarany

Sasagu Kurozumi

Chris C. Nolan

Maria Diez-Rodriguez

ANDREW GREEN ANDREW.GREEN@NOTTINGHAM.AC.UK
Associate Professor

EMAD RAKHA Emad.Rakha@nottingham.ac.uk
Professor of Breast Cancer Pathology

Citation

Johnston, S. J., Ahmad, D., Aleskandarany, M. A., Kurozumi, S., Nolan, C. C., Diez-Rodriguez, M., …Rakha, E. A. (2018). Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair. BMC Cancer, 18, Article 1027. https://doi.org/10.1186/s12885-018-4924-2

Journal Article Type	Article
Acceptance Date	Oct 9, 2018
Online Publication Date	Oct 23, 2018
Publication Date	Oct 23, 2018
Deposit Date	Oct 19, 2018
Publicly Available Date	Oct 19, 2018
Journal	BMC Cancer
Electronic ISSN	1471-2407
Publisher	Springer Verlag
Peer Reviewed	Peer Reviewed
Volume	18
Article Number	1027
DOI	https://doi.org/10.1186/s12885-018-4924-2
Keywords	Breast cancer; P38; MAPK; Oestrogen receptor; Adjuvant; Survival; Prognosis
Public URL	https://nottingham-repository.worktribe.com/output/1176745
Publisher URL	https://bmccancer.biomedcentral.com/articles/10.1186/s12885-018-4924-2
Contract Date	Oct 19, 2018